Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
Tue, November 28, 2023
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
Ed Arce Reiterated (ARCT) at Strong Buy and Held Target at $51 on, Nov 28th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy and Held Target at $51 on, Nov 28th, 2023.
Ed has made no other calls on ARCT in the last 4 months.
There is 1 other peer that has a rating on ARCT. Out of the 1 peers that are also analyzing ARCT, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $54 on, Tuesday, August 22nd, 2023
